
PERINANAL FISTULA
PERIANAL FISTULA IS A COMMON DISORDER THAT OFTEN RECURS.
A perianal fistula is an artificial tunnel that, in the majority of cases, develops from an infection that begins within a blocked anal gland. If the infection cannot be cleared from the anal gland an abscess forms and the infection burrows though muscles in the rectum and exits externally at the buttocks. Although perianal fistula has been recognized for thousands of years, the treatment of complex or recurrent perianal fistula continues to challenge surgeons today.
QUALITY OF LIFE
Patients endure a poor quality of life, experiencing pain, suffering and discharge from the tract and
related abscesses.
AN EFFECTIVE CURE
Patients and their physicians are dissatisfied with current treatment options, which are not effective for curing
anal fistula.
SUCCESS RATES
Current treatments have varied success rates, with many carrying the risk of causing permanent incontinence, inadequate healing, and repeat surgeries.
THE NUMBERS
There are 64,000 annual surgical procedures done to treat anal fistula in the U.S. alone.
WE BELIEVE IT'S TIME FOR A BETTER SOLUTION
TO TREAT PERIANAL FISTULA
BioHealx™ Technology

BioHealx™ is an investigational, minimally invasive technology designed to offer a single-operation, effective solution for healing anal fistulas, eliminating the need for patients
to undergo multiple procedures.


Featuring a bioabsorbable implant, BioHealx™ technology
is designed to:
-
Securely close and heal the fistula tract, dissolving in the body after treatment.
-
Prevent reinfection, protect continence, and drastically improve patients' quality of life.
-
Reduce complications and lower the cost of treatment for patients, and for the healthcare system as a whole.
ABOUT US
WE ARE DEVELOPING NOVEL MINIMALLY INVASIVE TECHNOLOGIES TO TREAT COLORECTAL DISEASES
Signum Surgical is committed to developing innovative solutions to treat patients with colorectal diseases, starting with anal fistula. After a year of exploring the needs of gastrointestinal and colorectal care, Eoin Bambury and Moshe Zilversmit founded the company in 2016 as a spin-out of the National University of Ireland BioInnovate programme. The company, headquartered in Galway, Ireland, plans to conduct a first-in-human study of BioHealx™ technology in the first half of 2019.


EOIN BAMBURY
CO FOUNDER / CTO
Over 17 years R&D experience in new medical device development. Eoin has contributed to the development of six medical devices currently on the market and is a named author on eight patent filings. Eoin was awarded 'Chartered Engineer of the Year 2012' from Engineers Ireland.
BOARD MEMBERS

JEFF GRAINGER
NON EXECUTIVE DIRECTOR
& BOARD CHAIRMAN
Over 20 years experience in the medical device industry, where he was most recently Managing Partner and The Foundry, a leading medical device incubator that has started more than a dozen pioneering companies that have transformed the treatment of a variety of widespread diseases. Jeff is trained as mechanical engineer and patent attorney.
ALAN LEVY

NON EXECUTIVE DIRECTOR
Alan has over 40 years of medical device industry experience. Alan has been involved with multiple life science companies as a CEO and as a board member and is a Senior Advisor to Frazier Healthcare Partners. Alan is currently the CEO of Chrono Therapeutics. Alan is an expert in bioabsorbable materials and the inventor of Vicryl, bioabsorbable suture.

DECLAN QUINN
NON EXECUTIVE DIRECTOR
Over 20 years of leadership experience in the medical device industry, focused on products and technologies for minimally invasive procedures, and specialised in product & technology transfer management. Declan's core degree is in Mechanical Engineering. He is an active supporter of medical device start-up companies.
ABOUT US
STAY UP TO DATE WITH THE LATEST NEWS FROM SIGNUM SURGICAL







SUPPORT & INVESTORS
WANT TO WORK WITH US?
email us at: careers@signumsurgical.com
